- Home
- MRNA vs LDOS Comparison
MRNA vs LDOS Comparison
Compare MRNA & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- LDOS
- Stock Information
- Founded
- MRNA 2010
- LDOS 1969
- Country
- MRNA United States
- LDOS United States
- Employees
- MRNA N/A
- LDOS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- LDOS EDP Services
- Sector
- MRNA Health Care
- LDOS Technology
- Exchange
- MRNA Nasdaq
- LDOS Nasdaq
- Market Cap
- MRNA 10.6B
- LDOS 17.7B
- IPO Year
- MRNA 2018
- LDOS 2006
- Fundamental
- Price
- MRNA $24.66
- LDOS $156.03
- Analyst Decision
- MRNA Hold
- LDOS Buy
- Analyst Count
- MRNA 20
- LDOS 13
- Target Price
- MRNA $51.94
- LDOS $184.25
- AVG Volume (30 Days)
- MRNA 8.6M
- LDOS 1.4M
- Earning Date
- MRNA 05-01-2025
- LDOS 05-06-2025
- Dividend Yield
- MRNA N/A
- LDOS 1.03%
- EPS Growth
- MRNA N/A
- LDOS 325.56
- EPS
- MRNA N/A
- LDOS 9.91
- Revenue
- MRNA $3,177,000,000.00
- LDOS $16,932,000,000.00
- Revenue This Year
- MRNA N/A
- LDOS $4.87
- Revenue Next Year
- MRNA $22.14
- LDOS $3.65
- P/E Ratio
- MRNA N/A
- LDOS $15.61
- Revenue Growth
- MRNA N/A
- LDOS 7.75
- 52 Week Low
- MRNA $23.15
- LDOS $123.62
- 52 Week High
- MRNA $170.47
- LDOS $202.90
- Technical
- Relative Strength Index (RSI)
- MRNA 42.25
- LDOS 73.28
- Support Level
- MRNA $23.70
- LDOS $144.63
- Resistance Level
- MRNA $28.52
- LDOS $156.77
- Average True Range (ATR)
- MRNA 1.34
- LDOS 3.55
- MACD
- MRNA -0.03
- LDOS 0.94
- Stochastic Oscillator
- MRNA 29.80
- LDOS 89.33
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About LDOS Leidos Holdings Inc.
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.